Updated Jul 16, 2026
STAAB THOMAS R II has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Thomas R. Staab II is the Chief Financial Officer of Lensar, Inc., a medical device company focused on cataract laser systems, as indicated by the most recent SEC insider filing dated January 13, 2026. The filing lists Staab in the CFO role with no reported stock purchases or sales. Lensar develops and markets the LENSAR Laser System designed to aid imaging, planning, and precision in cataract surgery.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-13 | TENX | TENAX THERAPEUTICS, INC. | A — Grant or award | 10.0K | $0.00 | |
| 2026-05-08 | LNSR | LENSAR, Inc. | F — Tax withholding / forfeiture | 1.4K | $5.38 | $7K |
| 2026-03-19 | LNSR | LENSAR, Inc. | M — Option exercise | 5.5K | $2.65 | $15K |
| 2026-02-20 | LNSR | LENSAR, Inc. | F — Tax withholding / forfeiture | 1.1K | $11.32 | $12K |
| 2026-01-13 | LNSR | LENSAR, Inc. | F — Tax withholding / forfeiture | 1.8K | $11.57 | $21K |
Thomas R. Staab II is the Chief Financial Officer of Lensar, Inc., a medical device company focused on cataract laser systems, as indicated by the most recent SEC insider filing dated January 13, 2026. The filing lists Staab in the CFO role with no reported stock purchases or sales. Lensar develops and markets the LENSAR Laser System designed to aid imaging, planning, and preci…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live STAAB THOMAS R II profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.